Transfusions and Hospice Care: A Path Forward?

Transfusions and Hospice Care: A Path Forward?

For some patients with advanced blood cancers, enrolling in hospice care can mean forgoing access to palliative transfusions that can help alleviate fatigue, shortness of breath or bleeding related to low blood counts.

Thomas LeBlanc, MD, MA

Thomas LeBlanc, MD, MA, a hematologic oncologist at Duke Cancer Center who treats patients with acute leukemias and various myeloid diseases and is board-certified in hospice and palliative medicine, described this scenario—deciding between palliative transfusions or home-based hospice care—as an “awful, impossible choice” for patients and their families. Patients may be told they can continue supportive care, including transfusions and antimicrobials, to help manage debilitating symptoms. But they may also be told they cannot elect hospice if they want to continue transfusions.

“In many areas, patients can’t do both,” he said. “I’ve seen several cases where patients were incredibly distraught about being forced to give up transfusions and felt it was unfair to choose between receiving help at home through hospice services and continuing transfusions that made them feel better. It becomes a deeply distressing situation. When we’re able to offer both, you can see the relief. It’s palpable.”

    

Log in to read the full article.

This article is reserved for AABB members.
Please log in or join AABB to continue reading.

Exception occured while executing the controller. Check error logs for details.


Exception occured while executing the controller. Check error logs for details.

Find More News

transfusion journal

Transfusion Journal

Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.

Learn More About Transfusion Journal
CellSource

AN UPDATE ON THE LATEST BIOTHERAPIES NEWS

Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.

Read and Subscribe Today

CONTACT US

To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.

CONNECT WITH US

AABB News

President

Meghan Delaney, DO, MPH

Chief Executive Officer

Debra Ben Avram, FASAE, CAE

Chief Communications and Engagement Officer

Julia Zimmerman

Director of Marketing and Communications

Jay Lewis, MPH

Managing Editor

Kendra Y. Mims, MFA

Senior Communications Manager

Drew Case

AABB News

(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.

AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.

+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.

Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.

2025 APEX Awards for Publication Excellence